First release of the m-RESIST Solution

blog image

First release of the m-RESIST Solution

During the second year, all the efforts have been put in the actual development and testing of the m-RESIST Tools. Activities range from working together with the clinical partners to specify user requirements, agile implementation and applied testing and evaluation. In short: the envisioned solution is now available for piloting. 

An overview of the m-RESIST solution is presented as follows. 

The m-RESIST solution is an innovative disease management system based on mobile technologies, addressed to empower patients with treatment-resistant schizophrenia (TRS), which will engage them, together with the professionals and caregivers, in active participation in therapeutic processes, enabling them to better self-manage their condition.

m-RESIST provides a different set of tools and functionalities addressed to patients, caregivers and health professionals, which rely on three main tools: two user interfaces and one back-end system. These tools are: first, a mobile app installed on a smartphone connected to a smartwatch for patients and caregivers; second, a web-based dashboard for follow-up and monitoring for clinicians; and third, a back-end system for managing patient data, interventions and communication between patients, caregivers and clinicians. 

The m-RESIST platform considers specific mHealth intervention modules specially designed for patients with treatment-resistant schizophrenia. The different interventions defined in the project have been divided into two main categories, Basal modules (Symptom Management-CBTp, Treatment Adherence, Healthy Lifestyle,) that are oriented to develop abilities in the patient; and Risk modules (Symptom Management-Risk), that is oriented to deal with specific problems, especially in risk situations.

The main aim of the m-RESIST therapeutic process is to engage TRS patients, together with the caregivers, in active participation in therapeutic processes, and at empowering them, enabling to self-manage their condition. This process intends to be tailored to user needs, and the main actors involved in the deployment of the interventions are the psychiatrists, psychologists, case managers and nursing staff. The process to follow consists of three stages: training, pre-intervention, and intervention.